Paul P. Carbone
#90,270
Most Influential Person Now
Paul P. Carbone's AcademicInfluence.com Rankings
Paul P. Carbonemedical Degrees
Medical
#941
World Rank
#1211
Historical Rank
Oncology
#31
World Rank
#33
Historical Rank
Download Badge
Medical
Why Is Paul P. Carbone Influential?
(Suggest an Edit or Addition)Paul P. Carbone's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Toxicity and response criteria of the Eastern Cooperative Oncology Group (1982) (9612)
- Report of the Committee on Hodgkin's Disease Staging Classification. (1971) (4217)
- Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. (1992) (1132)
- Combination chemotherapy in the treatment of advanced Hodgkin's disease. (1970) (1106)
- Aspergillosis. The spectrum of the disease in 98 patients. (1970) (958)
- Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women (1988) (842)
- Assessment of response to therapy in advanced breast cancer. (1977) (770)
- 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. (1975) (704)
- Ectopic production of human chorionic gonadotrophin by neoplasms. (1973) (551)
- Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland (1977) (534)
- Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. (1980) (450)
- The health consequences of smoking. Cancer. (1992) (424)
- Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. (1977) (385)
- Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. (1990) (292)
- THE DISTRIBUTION OF THE PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA. (1963) (272)
- Clinical trials and drug toxicity in the elderly. The experience of the eastern cooperative oncology group (1983) (264)
- Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. (1987) (259)
- Cancer treatment and age: patient perspectives. (1993) (256)
- L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. (1969) (255)
- A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy (1978) (230)
- Vincristine treatment of advanced cancer: a cooperative study of 392 cases. (1973) (228)
- Elevated antibody titers to epstein‐barr virus in Hodgkin's disease (1971) (227)
- Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962. (1965) (225)
- Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. (1967) (224)
- Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients. (2003) (222)
- L‐phenylalanine mustard (L‐PAM) in the management of primary breast cancer: An update of earlier findings and a comparison with those utilizing L‐PAM plus 5‐fluorouracil (5‐FU) (1977) (190)
- Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. (1967) (174)
- Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). (1968) (173)
- Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. (2001) (173)
- THE FUNCTION AND FATE OF TRANSFUSED LEUKOCYTES FROM DONORS WITH CHRONIC MYELOCYTIC LEUKEMIA IN LEUKOPENIC RECIPIENTS (1964) (168)
- Pseudomonas pneumonia. A retrospective study of 36 cases. (1973) (166)
- Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. (1971) (157)
- Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial (1978) (154)
- Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. (1967) (153)
- Assessment of response to therapy in advanced breast cancer: A project of the Programme on Clinical Oncology of the International Union against Cancer, Geneva, Switzerland (1977) (152)
- Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. (1969) (147)
- Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. (1994) (146)
- Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. (1968) (132)
- Clinical studies with vincristine. (1963) (132)
- Melphalan and prednisone: An effective combination for the treatment of multiple myeloma (1973) (131)
- Treatment of Burkitt's tumor with cyclophosphamide (1970) (116)
- In vitro growth of normal and leukemic human bone marrow. (1971) (111)
- UREASE CATALYSIS. II. INHIBITION OF THE ENZYME BY HYDROXYUREA, HYDROXYLAMINE, AND ACETOHYDROXAMIC ACID. (1965) (108)
- Summary of infectious complications occurring in patients with Hodgkin's disease. (1966) (103)
- Recovery of cytomegalovirus from adults with neoplastic disease. (1966) (102)
- Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. (1966) (101)
- Lymphoma of the Breast (1981) (100)
- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer (2010) (94)
- The Philadelphia chromosome and chronic myelogenous leukemia. (1966) (93)
- Burkitt's tumor in the United States (1969) (92)
- The Transfusion of Leukocytes from Donors with Chronic Myelocytic Leukemia to Patients with Leukopenia * (1966) (90)
- L-asparaginase toxicity. (1969) (87)
- Randomized Phase I Chemoprevention Dose-Seeking Study of α-Difluoromethylornithine (1993) (85)
- A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma: An ECOG study (1987) (83)
- Palliative medicine in the elderly (1997) (81)
- Pseudohyperkalemia due to release of potassium from white blood cells during clotting. (1966) (79)
- Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5‐fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An eastern cooperative oncology group trial (1990) (79)
- Central nervous system involvement in Burkitt's lymphoma. (1970) (78)
- Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group. (1982) (77)
- Chemotherapy of disseminated breast cancer: Current status and prospects (1977) (76)
- Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung. (1976) (76)
- Extrapulmonary Small‐Cell Carcinoma: A REVIEW OF THE LITERATURE WITH EMPHASIS ON THERAPY AND OUTCOME (1987) (74)
- Lung cancer: perspectives and prospects. (1970) (73)
- Plasma cell myeloma with D-myeloma protein (IgD myeloma). (1968) (72)
- Persistent Mitosis of Transfused Homologous Leukocytes in Children Receiving Antileukemic Therapy (1963) (71)
- METASTATIC EMBRYONAL CARCINOMA OF THE TESTIS ASSOCIATED WITH ELEVATED PLASMA TSH-LIKE ACTIVITY AND HYPERTHYROIDISM. (1964) (71)
- Hydroxyurea: Mechanism of Action (1963) (69)
- Inhibition of the primary immune response in man by anti-metabolites. (1965) (67)
- EFFECTS OF INTENSIVE PLASMAPHERESIS ON NORMAL BLOOD DONORS. (1964) (67)
- A controlled trial of urethane treatment in multiple myeloma. (1966) (65)
- Clinical trials of hydroxyurea in patients with cancer and leukemia (1964) (63)
- Perspectives on prevention and treatment of cancer in the elderly (1983) (62)
- Prophylactic versus no brain irradiation in regional small cell lung carcinoma (1985) (62)
- Approaches to improving the chemotherapy of Hodgkin's disease. (1966) (60)
- Cytogenetic and morphologie abnormalities in human bone marrow cells during cytosine arabinoside therapy. (1966) (56)
- Neoplasms of the large bowel following ureterosigmoidostomy. (1977) (55)
- Funding for patient-oriented research. Critical strain on a fundamental linchpin. (1997) (54)
- Serial in vitro marrow culture in acute myelocytic leukemia. (1973) (54)
- Burkitt's Tumor (1969) (53)
- Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A. (1972) (52)
- Chronic myelocytic leukemia with two Philadelphia chromosomes and prominent peripheral lymphadenopathy. (1967) (52)
- Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer. (1989) (52)
- The variable transformation in metastases from testicular germ cell tumors: the need for selective biopsy. (1981) (50)
- Acetohydroxamate: Bacterial Urease Inhibitor with Therapeutic Potential in Hyperammonaemic States (1965) (50)
- Aggressive combined modality therapy for advanced local-regional breast carcinoma. (1984) (50)
- Effects of chemotherapeutic agents on normal mouse bone marrow grown in vitro. (1971) (49)
- Cooperative groups and community hospitals. Measurement of impact in the community hospitals (1983) (48)
- Cancer chemotherapy in the elderly. (1989) (46)
- Eastern cooperative oncology group experience with the rappaport classification of non‐Hodgkin's lymphomas (1979) (46)
- Normal immunologic reactivity in patients with the lymphoma mycosis fungoides (1966) (45)
- Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine. (1998) (45)
- Combined modality treatment of regional small cell undifferentiated carcinoma of the lung: a cooperative study of the RTOG and ECOG. (1981) (45)
- Assessment of response to therapy in advanced breast cancer (an amendment) (1978) (42)
- Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study. (1985) (42)
- Close Association of I Blood Group and Disease (1964) (41)
- Eastern Cooperative Oncology Group studies with DTIC (NSC-45388). (1976) (41)
- Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine. (1993) (40)
- CYTOGENETICALLY ABNORMAL CELL S IN VITRO IN ACUTE LEUKÆMIA (1972) (40)
- Serum alpha‐fetoprotein in 184 ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations (1974) (39)
- α-Fetoprotein in Monkeys With Hepatoma (1969) (39)
- Androgenic hormones and human granulopoiesis in vitro. (1974) (38)
- Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma (1988) (38)
- The eastern cooperative oncology group experience with cyclophosphamide, adriamycin, and 5‐fluorouracil (CAF) in patients with metastatic breast cancer (1985) (37)
- Granulocyte-macrophage colony-stimulating factor and vasculitis. (1989) (36)
- A clinical evaluation of dose and schedule of administration of cytosine arabinoside (NSC 63878). (1968) (35)
- Survival of nodular versus diffuse pattern lymphocytic poorly differentiated lymphoma (1978) (35)
- Non‐Hodgkin's lymphoma: Recent observations on natural history and intensive treatment (1972) (34)
- THE EFFECT OF PREDNISONE ON CALCIUM METABOLISM AND CA47 KINETICS IN PATIENTS WITH MULTIPLE MYELOMA AND HYPERCALCEMIA. (1964) (34)
- Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones". (1979) (34)
- THE EFFECT OF TREATMENT IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA. BIOCHEMICAL STUDIES. (1963) (33)
- Repeated Leukapheresis of Patients with Chronic Myelocytic Leukemia (1966) (33)
- SERUM α-FETOPROTEIN IN THE U.S.A. (1970) (33)
- Preliminary clinical studies with ibenzmethyzin (1966) (32)
- Nodular mixed lymphocytic‐histiocytic lymphoma (NM) response and survival (1980) (32)
- Immunologic studies in Burkitt's lymphoma (1970) (32)
- Spontaneous remission in diffuse large cell lymphoma (1986) (31)
- Intensive chemotherapy in patients with generalized Burkitt's lymphoma (1972) (31)
- Bone Marrow Involvement in Burkitt's Lymphoma: Results of a Prospective Study (1972) (29)
- Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants. (2001) (29)
- Current Therapy in Hematology-Oncology (1995) (29)
- Serial in vitro bone marrow culture in acute lymphocytic leukemia. (1973) (28)
- Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas. A progress report (1976) (28)
- Comparative trial of adriamycin and 5-fluorouracil in advanced prostatic cancer--progress report. (1977) (28)
- Serum immune globulin concentrations in acute leukemia during intensive chemotherapy (1965) (28)
- Randomized phase II-III trial of combination beta and gamma interferons and etoposide and cisplatin in inoperable non-small cell cancer of the lung. (1989) (27)
- Combination chemotherapy in accelerated phase of chronic granulocytic leukemia. (1969) (27)
- Endometrial cancer: approach to development of effective chemotherapy. (1974) (26)
- Adenosylmethionine Elevation in Leukemic White Blood Cells (1965) (26)
- Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer (1992) (26)
- Multiple myeloma in spouses. (1971) (26)
- STUDIES OF THE PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (1964) (25)
- A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effects (1986) (24)
- THE EFFECT OF TREATMENT IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA. HEMATOLOGIC AND CYTOGENETIC STUDIES. (1963) (24)
- Combination chemotherapy of the malignant lymphomas. A Controlled clinical trial (1976) (24)
- CLINICAL AND BIOCHEMICAL EFFECTS OF CYCLOPHOSPHAMIDE IN PATIENTS WITH MALIGNANT CARCINOID. (1965) (24)
- Randomized trial of initial therapy with melphalan versus cisplatin‐based combination chemotherapy in patients with advanced ovarian carcinoma: Initial and long term results—Eastern Cooperative Oncology Group study E2878 (1996) (24)
- Adjuvant systemic therapy (1990) (24)
- Treatment of Hodgkin's disease. (1967) (23)
- Chemotherapeutic implications of staging in Hodgkin's disease. (1971) (23)
- Training program in medical oncology. (1973) (23)
- Procarbazine therapy for Hodgkin's disease in early pregnancy. (1968) (22)
- Breast cancer adjuvant therapy (1990) (22)
- Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancer. (1978) (21)
- Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection (1968) (21)
- Cerebellar degeneration with hodgkin's disease (1979) (21)
- Hypoalbuminemic and hypocholesterolemic effect of L-asparaginase (NSC-109,229) treatment in man--a preliminary report. (1969) (21)
- Inhibition of phorbol ester--induced human epidermal ornithine decarboxylase activity by oral compounds: a possible role in human chemoprevention studies. (1985) (21)
- Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma. (1987) (21)
- Higher Serum TSH Level in Thyroid Nodule Patients is Associated with Greater Risks of Differentiated Thyroid Cancer and Advanced Tumor Stage (2007) (21)
- In vitro induction of human skin ornithine decarboxylase by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. (1985) (20)
- Adriamycin in the treatment of far-advanced lung cancer. (1976) (20)
- SECONDARY ASPERGILLOSIS. (1964) (20)
- Splenectomy for thrombocytopenia in chronic granulocytic leukemia (1972) (19)
- Pharmacologic management of cancer pain. (2007) (19)
- Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5‐fluorouracil and streptozotocin plus cyclophosphamide (1977) (19)
- Infectious mononucleosis followed by Burkitt's tumor. (1970) (18)
- Cytogenetically abnormal cells in vitro in acute leukaemia. (1972) (18)
- Advances in the systemic treatment of cancers in the elderly. (2000) (18)
- Chemotherapy in the treatment strategy of breast cancer (1975) (18)
- Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non‐lymphocytic leukemia in adults (1980) (18)
- Cryofibrinogenemia, multiple dysproteinemias, and hypervolemia in a patient with a primary hepatoma. (1966) (18)
- Combination Chemotherapy for Advanced Disease (1977) (17)
- Burkitt's tumor in the United States. (1969) (17)
- VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474). (1979) (17)
- Implications of the 99mTc diphosphonate bone scan on treatment of primary breast cancer. (1977) (17)
- Treatment of Burkitt's lymphoma with cyclophosphamide. (1970) (16)
- Elevated plasma levels of a hydroxyproline-containing protein in Hodgkin's disease and their relation to disease activity. (1966) (16)
- STUDIES OF CALCIUM METABOLISM IN MULTIPLE MYELOMA WITH CALCIUM AND METABOLIC-BALANCE TECHNIQUES. (1963) (16)
- Hodgkin's disease. Combined clinical staff conference at the National Institutes of Health. (1967) (16)
- Erythroid homograft following leukocyte transfusion in a patient with acute leukemia. I. Clinical studies and implications. (1965) (16)
- Spontaneous remission in diffuse large cell lymphoma. (1986) (15)
- Studies on the Anti-Tumor Action of Poly I: Poly C (1971) (15)
- In vitro granulocyte production in patients with Hodgkin's disease and lymphocytic, histiocytic, and mixed lymphomas. (1975) (15)
- A phase II study of neocarzinostatin (NSC 157365) in malignant hepatoma (1980) (15)
- Clinical trial of vinblastine in multiple myeloma. (1963) (14)
- Phase II study of adriamycin and bleomycin in patients with multiple myeloma. (1978) (14)
- Bioavailability Study of Oral Liquid and Tablet Forms of α-Difluoromethylornithine (2000) (14)
- Diffuse well‐differentiated lymphocytic lymphoma (DLWD). Response and survival (1978) (14)
- Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice. (1967) (14)
- Issues in treatment (1991) (14)
- Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine. (1986) (14)
- Priapism in a child with chronic granulocytic leukemia. (1969) (13)
- Prognostic factors in invasive gallbladder carcinoma (1983) (13)
- Proliferative activity of human granulocytes, as estimated quantitatively by in vitro colony formation. (1972) (13)
- Effectiveness of methyl-GAG (NSC-32946) administered intramuscularly. (1974) (13)
- Amplification of colony stimulating activity in human serum by interaction with CSA from other sources. (1975) (13)
- Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience. (1977) (12)
- Effect of sodium fluoride therapy on calcium metabolism in multiple myeloma. (1966) (12)
- Capillary tube scanning applied to in vitro mouse marrow granulocyte growth. (1973) (11)
- Organizing multicenter trials: lessons from the cooperative oncology groups. (1991) (11)
- Clinical experience with L-asparaginase. (1970) (10)
- Immunologic studies in American patients with Burkitt-like lymphoma. (1967) (10)
- The development and use of an intravenous preparation of allopurinol. (1968) (10)
- Pharmacokinetic considerations in the design of optimal chemotherapeutic regimens for the treatment of breast carcinoma: a comceptual approach. (1976) (10)
- Fluoride effect on bone in plasma cell myeloma. (1968) (10)
- Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma. (1976) (9)
- Clinical and chemotherapeutic study of hepatocellular carcinoma in Malaysia. A comparison with African and American patients (1982) (9)
- A lesson from the mammography issue. (1978) (8)
- Cryptococcus neoformans pericarditis associated with Hodgkin's disease. (1966) (8)
- Eastern cooperative oncology group experience with prognostically favorable non-Hodgkins lymphomas (1981) (8)
- The role of chemotherapy in the treatment of cancer of the breast. (1975) (8)
- Experience with an automated cancer protocol surveillance system. (1983) (8)
- Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group. (1976) (8)
- The feasibility of using randomization schemes early in the clinical trials of new chemotherapeutic agents: Hydroxyurea (NSC‐32065) (1965) (8)
- Burkitt’s Tumor: A Comparative Study in Africa and the United States (1971) (7)
- Systemic treatment of breast cancer: past, present and future. (1976) (7)
- Progress in the systemic treatment of cancer.Concepts, trials, drugs, and biologics (1990) (7)
- NIH clinical staff conference. Burkitt's tumor. (1969) (7)
- Effect of L-asparaginase on mouse bone marrow, assayed by in vitro culture. (1970) (7)
- Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung. (1976) (7)
- High-dose chemotherapy for breast cancer. (1987) (7)
- Antiestrogens and Breast Cancer Treatment (1975) (7)
- Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275). (1979) (7)
- Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma. (1984) (6)
- A phase I study of 5-fluorouracil, leucovorin and levamisole (1997) (6)
- Pharmacologic Management of Cancer Pain: Case Commentary (1995) (6)
- Adjuvant therapy of stage II breast cancer (1990) (6)
- The clinical investigator and the evolution of the treatment of primary breast cancer. (1986) (6)
- Special report. Steriod receptors in breast cancer. (1979) (6)
- Cancer in the Elderly: Tailoring Treatment (2000) (6)
- Fourteen‐year remission of acute leukemia in a patient exposed to thorotrast (1976) (6)
- EFFECT OF THORACIC DUCT LYMPH DRAINAGE ON THE IMMUNE RESPONSE IN MAN. (1965) (6)
- Retinoids as Inhibitors of Tumor Promotion1 (1985) (6)
- Quality of institutional participation in multicenter trials. (1982) (6)
- Cancer biology and cancer cures: reflections of a clinical investigator: presidential address. (1981) (6)
- Transplantable mouse plasma cell tumors in experimental chemotherapy. (1969) (5)
- Hepatocellular carcinoma in the very elderly: to treat or not to treat? (1994) (5)
- Management of patients with non-Hodgkin's lymphoma. (1973) (5)
- Clinical efficacy and lack of toxicity of allopurinol (NSC-1390) given intravenously. (1970) (5)
- Parameters of marrow proliferative capacity in vitro: detection of a sex difference in normal human granulopoiesis. (1974) (5)
- Evaluation of tryptophan mustard (NSC-62403) in patients with plasmacytic myeloma. (1967) (5)
- Aspergillosis: A Disease Associated with Impaired Host Resistance. (1962) (5)
- Clinical trial of vinleurosine sulfate (NSC-90636): a new drug derived from Vinca rosea Linn. (1966) (5)
- Myotonic dystrophy and leukemia. (1969) (5)
- Review: adjuvant hormonotherapy for breast cancer (1986) (5)
- A randomized study of post-operative radiotherapy combined with chemotherapy in rectal carcinoma: An eastern cooperative oncology group study (1981) (5)
- Immunologic function during adjuvant BCG immunotherapy for malignant melanoma: Induction of anergy (1979) (5)
- Bioavailability study of oral liquid and tablet forms of alpha-difluoromethylornithine. (2000) (5)
- Cavitating splenic infarction. (1974) (5)
- Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide. (1977) (4)
- Neoplastic Plasma Cell: Combined Clinical Staff Conference at the National Institutes of Health (1963) (4)
- A progress report of cancer centers and tribal communities: Building a partnership based on trust (1996) (4)
- Immunosuppression with lymph depletion in man. (1967) (4)
- Breast cancer: changing strategy for treatment. (1977) (4)
- Organization of clinical oncology in the U.S.A.: role of cancer centers, cooperative groups and community hospitals. (1985) (4)
- Therapy of the Blastic Phase of Chronic Granulocytic Leukemia (1970) (4)
- Chemotherapy administration to the Elderly patient (1985) (4)
- 6-THIOGUANINE (NSC-752)-1 THERAPY IN PATIENTS WITH MULTIPLE MYELOMA. (1964) (4)
- Combined Modality Treatment of Local Regionally Advanced Breast Cancer Patients: 5 to 10 Year Follow‐Up (1989) (4)
- Short term high density systemic therapy for metastatic breast cancer (2005) (4)
- PRELIMINARY STUDIES WITH 5-BIS(2-CHLOROETHYL)AMINO-DL-TRYPTOPHAN (NSC-62403) IN ANIMALS AND MAN. (1964) (4)
- Preliminary studies with dibromomannitol (NSC-94100) in patients with chronic myelogenous leukemia. (1967) (3)
- Tumor biology and clinical trials: the Richard and Hinda Rosenthal Foundation Award Lecture. (1977) (3)
- Cancer control and the older person. Issues in treatment. (1991) (3)
- Outpatient Management of Advanced Cancer: Symptom Control, Support, and Hospicein-the-Home (1986) (3)
- Current Therapy in Hematology-Oncology, 1985-1986 (1983) (3)
- Aspergillosis infection following radiotherapy. (1984) (3)
- Phase I-II trial of intramuscularly administered bleomycin. (1977) (3)
- Enhancement of antitumor effect of alkylating agents by vitamin a. Abstr. (1969) (3)
- Alpha-fetoprotein in monkeys with hepatoma. (1969) (3)
- The role of chemotherapy in the treatment of breast cancer. (1976) (3)
- Phase II Evaluation of Menogaril in Advanced Prostate Cancer: Eastern Cooperative Oncology Group EST P-A885 (2001) (2)
- Cyclophosphamide toxicity in Ugandan and American patients with malignant lymphoma (1970) (2)
- Cardiac involvement in metastatic breast cancer. (1990) (2)
- Myeloma of bone treated with sodium fluoride. (1968) (2)
- Radiation-induced carcinoma of the thyroid with severe thyrotoxicosis. (1978) (2)
- Doxorubicin as adjuvant therapy for breast cancer: answers or more questions? (1989) (2)
- REPORT ON WORKSHOP SESSION. CLINICAL EVALUATION, STAGING, AND PROGNOSIS. (1972) (2)
- Opinion: The case for clinical trials (1980) (2)
- L-asparaginase and Burkitt's lymphoma. (1969) (2)
- New Drugs in the Treatment of Acute Leukemia (1970) (2)
- Phase I Chemoprevention Study of Piroxicam and rn (1998) (2)
- Preliminary clinical trials and clinical pharmacologic studies with 5-(3,3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196) given orally. (1971) (2)
- Pala Versus Streptozotocin, Doxorubicin, and Meccnu in the Treatment of Patients With Advanced Pancreatic Carcinoma (1998) (2)
- Effect of disease on an expression of blood group I. (1965) (2)
- Medical treatment for advanced breast cancer. (1978) (2)
- Changing concepts of the treatment of primary breast cancer. (1976) (1)
- Paper electrophoresis of cerebrospinal fluid proteins in patients with meningeal leukemia (1964) (1)
- FUNDING FOR PATIENT-ORIENTED RESEARCH : CRITICAL STRAIN ON A FUNDAMENTAL LINCHPIN (1998) (1)
- American Burkitt's Lymphoma: Current Status. (1973) (1)
- A Progress Report Card (Second Edition) (2006) (1)
- The participation of community hospitals in cancer clinical trials: results and impact of the Eastern Cooperative Oncology Group Program. (1983) (1)
- Recruitment Strategies for Cancer Prevention Trials (2005) (1)
- Drug development in solid tumors: personal perspective of Dr. Emil J Freireich's contributions. (1997) (1)
- Management dilemmas in prostate cancer. (1996) (1)
- Measurement of reticuloendothelial system phagocytosis and catabolism: a new method. (1969) (1)
- What is the optimum number of agents (1978) (1)
- BIOLOGICAL VALIDATION OF HIGH THROUGHPUT MICROCHANNEL CULTURE (2008) (1)
- Options in breast cancer therapy. (1981) (1)
- ANDROGENS IN MULTIPLE MYELOMA (1961) (1)
- Management With Combination Therapy (1973) (1)
- Staging of Hodgkin's disease. (1979) (1)
- Adenocarcinoma of the liver without a detectable primary. (1991) (1)
- Developing a postgraduate medical oncology training program in Taipei, Taiwan, Republic of China. (1991) (1)
- Postoperative adjuvant therapy in rectal carcinoma: Experience of the eastern cooperative oncology group (ECOG)—Preliminary report (1981) (1)
- Hepatoma in the elderly--follow-up on a case report. (1996) (1)
- Drug Treatment of Breast Cancer (1978) (1)
- The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits. (1984) (1)
- Cancer in China. The report of the American cancer delegation visit to the People's Republic of China. Henry S. Kaplan and Patricia Jones Tsuchitani (eds). Alan R. Liss, Inc., New York, 1978. 248 pp. Price: $28.00 (1979) (1)
- Clinical Significance of the Philadelphia Chromosome in Chronic Granulocytic Leukemia. (1968) (1)
- Breast Cancer: 1. Screening and Early Management: Case Commentary (1994) (0)
- International workshop on surgical adjuvant antineoplastic chemotherapy in solid tumors. Conclusions and recommendations of the workshop. Recent results of surgical adjuvant chemotherapy. (1978) (0)
- THE FUNCTION AND FATE O F TRANSFUSED LEUKOCYTES IN LEUKOPENIC RECIPIENTS FROM DONORS WlTH CHRONIC MYELOCYTIC LEUKEMIA (2006) (0)
- Back Pain in the Elderly Patient: Case Commentaries (1993) (0)
- National meeting on breast cancer (2005) (0)
- Phase I evaluation of 773U82-HCl in a two-hour infusion repeated daily for three days (1992) (0)
- Cooperation between an academic subspecialty department and a community-based family medicine department: a developmental model. (1978) (0)
- Overview of the Wisconsin Clinical Cancer Center (WCCC). (1983) (0)
- Adjuvant therapy of breast cancer 1971–1981 (2005) (0)
- Editorial: Antiestrogens and breast cancer treatment. (1975) (0)
- Book ReviewLymphoproliferative Diseases. (1975) (0)
- Neoplastic Plasma Cell (2020) (0)
- BREAST CANCER. I: SCREENING AND EARLY MANAGEMENT. COMMENTARY (1994) (0)
- PROCARBAZINE THERAPY FOR HODGKINʼS DISEASE IN EARLY PREGNANCY (1969) (0)
- Current approaches to the management of patients with malignant lymphoma. (1967) (0)
- Breast cancer. (1994) (0)
- Biology and treatment of micrometastases in approach to breast cancer. (1978) (0)
- Breast cancer. (1987) (0)
- Cancer in the Elderly: Clinical and Biologic Considerations (1985) (0)
- Breast cancer. (1996) (0)
- Hormones and chemotherapy: To combine or not to combine (1984) (0)
- The Journal thanks the following consultants who, in addition to the members of the Editorial Board, gave their time to review manuscripts submitted in 1980. (1980) (0)
- National clinical Oncology Group to have headquarters in Madison. (1976) (0)
- Treatment-Relate d M yelodysplasia a nd A cute L eukemia i n Non-Hodgkin's L ymphoma P atients (2003) (0)
- Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: Preliminary results—the ECOG experience (2005) (0)
- Oncology Update for the Millennium (2000) (0)
- Medical Management of Gastrointestinal Cancer (1990) (0)
- Chemotherapy of mouse plasmacytomas, effects on host survival and abnormal protein synthesis. Abstr. (1969) (0)
- Chemoprevention: an oncologist's view. (1986) (0)
- Commentary (Carbone): Geriatric Syndromes and Assessment in Older Cancer Patients (2001) (0)
- Erythroid homograft following transfusion in a patient with acute leukemia (1966) (0)
- Cancer treatment combined modality approach. (1976) (0)
- In vitro assay of bone marrow suppression induced by anti-tumor drugs in mice. Abstr. (1970) (0)
- 90244353 Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer (1991) (0)
- Coarctation of the aorta from a mediastinal germ cell tumor: a case report. (1982) (0)
- Gastrointestinal Cancer (1990) (0)
- Breast Cancer: 2. Recurrent Disease: Case Commentary (1994) (0)
- Leukemia (CML) Clinical Implications of Cytogenetic Variants in Chronic Myelocytic (2011) (0)
- Augmenting Agents in Cancer Therapy (1981) (0)
- Current concepts in cancer: updated breast cancer--IV. Chemotherapy and locally advanced: what is the optimum number of agents? (1978) (0)
- Lysosomes, cortisone, and aspergillosis. (1968) (0)
- Hyperthermia in Cancer Therapy (1984) (0)
- Adjuvant hormonotherapy for breast cancer. (1986) (0)
- Combination chemotherapy for patients with malignant lymphoma. (1972) (0)
- 92103997 Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer (1992) (0)
- Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: clinical trials. (1972) (0)
- On authorship and acknowledgements. (1992) (0)
- A symposium on cancer chemotherapy. II. Malignant lymphoma and chronic leukemia. (1962) (0)
- Breast cancer. (1997) (0)
- Current chemotherapeutic combinations. (1973) (0)
- A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract (1989) (0)
- Breast cancer. (1993) (0)
- International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy. (1973) (0)
- The effect of thio purines upon lymphocytes lacking enz hypo xanthine guanine phosphoribosyl transferase abstract 6 mercapto purine thio inosinic acid human (1968) (0)
- New therapeutic approaches to low-grade B cell neoplasms. (1985) (0)
- Asparaginase: Early Clinical and Toxicology Studies (1970) (0)
- Manual of Cancer Chemotherapy (1983) (0)
- Recent advances in clinical oncology, Progress in Clinical and Biological Research, Vol 25, Tapan A. Hazra and Michael C. Beachley (eds). Alan R. Liss, Inc., New York, 1978. 182 pp. Price $16.00 (1979) (0)
- Randomized, three-step trial design for phase 1 study of chemopreventive agents (1992) (0)
- Midwinter Oncology Conference Designed for Radiation Oncologists The Los Angeles Radiological Society is sponsoring this Conference on (1980) (0)
- Progress in cancer treatment (1984) (0)
- Oestrogen Relevante of Cathepsin D versus Receptors in Node Negative Breast Cancers (1991) (0)
- Case report: cerebellar degeneration with Hodgkin's disease. (1979) (0)
- A progress report of cancer centers and tribal communities: Building a partnership based on trust (0)
This paper list is powered by the following services:
